Table of Contents Table of Contents
Previous Page  551 692 Next Page
Information
Show Menu
Previous Page 551 692 Next Page
Page Background

153 (68.3%) in patients with nonorthotopic bladder sub-

stitutes. From a clinical perspective, this finding is likely a

selection bias as patients with advanced tumor stage,

prostatic urethral disease, or extensive CIS were more likely

to receive incontinent diversions. However, one may also

hypothesize that connecting urothelial and intestinal tissue

induces immune reactions resulting in an enhancement of

the local immune response to carcinogenic antigens. A

recent study immunohistochemically investigated urethral

tissues obtained from seven neobladder patients and nine

healthy controls

[19]

. In neobladder patients, there was a

nonsignificant trend towards a higher relative fraction of B-

cells, especially CD138 positive plasma cells, and a lower

relative fraction of T-cells

[19]

. Yet, whether this immuno-

logical finding may be causative for the apparently lower

risk of secondary urethral tumors in neobladder patients is

unclear. This study lacked a comparative group of patients

undergoing cystectomy with ileal conduit. As studies

evaluating risk factors for secondary upper tract malignan-

cies did not find OBS to be associated with a reduced risk of

metachronous UTUC

[6]

, connecting urethral and intestinal

tissue may not per se induce immunological changes.

Instead, the constant flow of neobladder urine through the

retained urethra may lead to immuno-inductive processes.

Another possible explanation is the potential for earlier

diagnosis of recurrence in patients with orthotopic diver-

sion due to their voiding through the urethra. It is more

likely that conduit patients who develop urethral recur-

rence may also present with advanced disease due to a large

local recurrence. These considerations suggest that follow-

up for patients with ileal conduit should include urethral

inspection or cytology obtained with brushing.

3.2.

Accuracy and prognostic significance of frozen section

analysis of urothelial margins at RC

3.2.1.

Ureteral frozen section analysis

In contemporary RC series, the rate of positive ureteral

margins on permanent sections ranges between 6.8% and

14.0%

( Table 3

)

[20–23] .

Tumor multifocality

[23] ,

a positive

FSA of the distal ureter

[21,23]

, male sex

[21] ,

and the

presence of bladder CIS

[22,24]

were found to indepen-

dently predict malignancy at the distal ureteral margin on

permanent section. For ureteral FSA, the majority of studies

have reported sensitivity and specificity rates around

75–80% and 95–99%, respectively

[20,22,23,25]

. A large

study on 2047 patients treated with RC over a time period of

40 yr investigated the accuracy of intraoperative FSA of the

ureteral margins. The sensitivity of FSA for correctly

predicting the final ureteral margin status was only 59%

and showed only a moderate increase to 69% for CIS

[8]

. The

rate of secondary UTUC was noticeably low at 1.4% (

N

= 28)

and no recurrences were observed at the ureteroileal

anastomosis. A positive FSA was associated with meta-

chronous UTUC only in univariable analysis. In addition,

authors reported that 15 of the 28 patients (54%) with

subsequent UTUC had negative results for FSA of the

ureteral margins. While these data question the utility of

routine FSA for the intraoperative assessment of the distal

ureters, some consideration needs to be given to the

interpretation of these results. Although the sample size is

large, it covers a period of almost 40 yr which may have

implications on histopathologic assessment during the

study period. The reported sensitivity for the detection of

malignancy at the margin was considerably less than in

other series and the rate of metachronous UTUC after a

median follow-up of more than 12 yr was exceptionally low.

Malignant ureteral margins on permanent section show

CIS or severe dysplasia in more than 75% of the cases

[25]

. Various series have demonstrated that the presence of

CIS at the ureteral margin on permanent section after RC

carries an increased risk of metachronous UTUC

[22,23] .

Moreover, prior studies have suggested that patients with

SUTs at the ureteroileal anastomosis have a higher risk for

cancer-specific death compared with patients with proximal

tumors

[26,27]

. Thus, one may hypothesize that converting a

positive margin into a negative one by means of reresec-

tion(s) impacts favorably on prognosis. However, the

presence of

skip

lesions, or pagetoid spread, particularly

for CIS, limits the therapeutic value of obtaining a negative

FSA for preventing metachronous UTUC. A recent study

investigated the presence of

skip

lesions in patients who had

at least two resections of the same ureter at RC

[25] .

Skip

lesions were found in 5% of the patients, with CIS being the

most prevalent histological malignant entity.

Skip

lesions

were associated with lymphovascular invasion and non-

muscle invasive disease at RC and were also associated with

a lower overall survival. These findings suggest that

skip

Table 3 – Assessment of urothelial malignancy at radical cystectomy with different methods

Study

Site

Method

N

total

N

(malig.)

Sensitivity (%)

Specificity (%)

PPV (%)

NPV (%)

Accuracy

Satkunasivam [

[70_TD$DIFF]

8]

Ureter

FSA

2047

178 (8.6)

59

93

n.r.

n.r.

n.r.

Kim [

[71_TD$DIFF]

20]

Ureter

FSA

402

46 (11.2)

75

96

n.r.

n.r.

95

Osman [

[72_TD$DIFF]

21]

Ureter

FSA

100

14 (14.0)

45

98

81

91

n.r.

Raj [

[73_TD$DIFF]

22]

Ureter

FSA

1330

171 (12.9)

75

99

n.r.

n.r.

n.r.

Gakis [

[74_TD$DIFF]

23]

Ureter

FSA

218

15 (6.8)

74

100

94

99

98

Osman [

[75_TD$DIFF]

34]

Urethra

FSA

100

6 (6.0)

33

99

83

89

89

von Rundstedt [

[76_TD$DIFF]

39]

Urethra

TUPBx

272

101 (37.1)

71

100

100

86

89

Gaya [

[77_TD$DIFF]

40]

Urethra

TUPBx

234

81 (34.6)

81

82

62

92

n.r.

Ichihara [

[78_TD$DIFF]

63]

Urethra

TUPBx

101

25 (24.8)

86

91

72

96

n.r.

FSA = frozen section analysis; malig. = malignant;

N

= number of patients; NPV = negative predictive value; n.r. not reported; PPV = positive predictive value;

TUPBx = transurethral prostatic urethral biopsy.

E U R O P E A N U R O L O G Y 7 1 ( 2 0 1 7 ) 5 4 5 – 5 5 7

551